University of Southern California Keck School of Medicine is a clinical research site located in Los Angeles, California, United States.
Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Southern California Keck School of Medicine has participated in 19 clinical trials with 6 currently active.
Therapeutic areas: Recovery Following Partial Medial Meniscectomy, Acute Myeloid Leukemia, Myeloproliferative Neoplasm.
Sponsors: Mesoblast International Sàrl, Astex Pharmaceuticals, Inc., TVAX Biomedical.
Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Southern California Keck School of Medicine has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Southern California Keck School of Medicine has 19 clinical trials on record, with 6 currently active. Their work covers Recovery Following Partial Medial Meniscectomy, Acute Myeloid Leukemia, Myeloproliferative Neoplasm.
Yes — University of Southern California Keck School of Medicine holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.